Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression.

Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression.
Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 09;: Authors: Brunoni AR, Padberg F, Vieira ELM, Teixeira AL, Carvalho AF, Lotufo PA, Gattaz WF, Benseñor IM Abstract BACKGROUND: Transcranial direct current stimulation (tDCS) holds promise as a therapeutic intervention for major depressive disorder (MDD). A more precise understanding of its underlying mechanisms may aid in the identification of subsets of patients responsive to tDCS within the context of precision psychiatry. OBJECTIVE: In this ancillary investigation of the Escitalopram vs. Electrical Current Therapy for Treating Depression Clinical Study (ELECT-TDCS), ... read more
PubMed Transcranial Direct Current Stimulation